Eduardo Bruno Martins's Net Worth
$241 Thousand
Who is Eduardo Bruno Martins?
Eduardo Bruno Martins does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sagimet Biosciences Inc., and Eiger BioPharmaceuticals, Inc..
SEC CIK
Eduardo Bruno Martins's CIK is 0001670431
Past Insider Trading and Trends
2023 was Eduardo Bruno Martins's most active year for acquiring shares with 3 total transactions. Eduardo Bruno Martins's most active month to acquire stocks was the month of February. 2023 was Eduardo Bruno Martins's most active year for disposing of shares, totalling 2 transactions. Eduardo Bruno Martins's most active month to dispose stocks was the month of June. 2023 saw Eduardo Bruno Martins paying a total of $0.00 for 331,711 shares, this is the most they've acquired in one year. In 2024 Eduardo Bruno Martins cashed out on 8,357 shares for a total of $25,910.04, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sagimet Biosciences Inc. (SGMT) Snapshot price: $2.65
Chief Medical OfficerEduardo Bruno Martins owns 81,213 units of Series A Common Stock which is worth $215,214.45. In the year 2023 Eduardo Bruno Martins acquired a total of 89,570 shares in Sagimet Biosciences Inc., Eduardo also disposed a total of 8,357 shares of Sagimet Biosciences Inc. equalling to $25,910.04.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.33% | -8.36K |
$3.10 | -$25,910.04 | 81.21K |
Jul 19
| |||
Form 4
|
∞
| 89.57K |
—
|
—
| 89.57K |
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Eiger BioPharmaceuticals, Inc. (EIGR) No price found
SVP, Liver and Infectious Dise
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |